Human medicines European public assessment report (EPAR): Epoetin Alfa Hexal, epoetin alfa, Anemia;Kidney Failure, Chronic;Cancer, Date of authorisation: 27/08/2007, Revision: 24, Status: Authorised

Human medicines European public assessment report (EPAR): Binocrit, epoetin alfa, Anemia;Kidney Failure, Chronic, Date of authorisation: 28/08/2007, Revision: 22, Status: Authorised

Parallel distribution: Regulatory and procedural guidance

List of centrally authorised products requiring a notification of a change for update of annexes

Human medicines European public assessment report (EPAR): Prometax, rivastigmine, Alzheimer Disease;Parkinson Disease;Dementia, Date of authorisation: 03/12/1998, Revision: 46, Status: Authorised

Human medicines European public assessment report (EPAR): Fetcroja, cefiderocol, Gram-Negative Bacterial Infections, Date of authorisation: 23/04/2020, Revision: 7, Status: Authorised

Article 57 product data

Human medicines European public assessment report (EPAR): Respreeza, alpha1-proteinase inhibitor (human), Genetic Diseases, Inborn;Lung Diseases, Date of authorisation: 20/08/2015, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR): Olumiant, baricitinib, Arthritis, Rheumatoid, Date of authorisation: 13/02/2017, Revision: 17, Status: Authorised